Previous close | 8.00 |
Open | 8.00 |
Bid | 8.80 |
Ask | 11.90 |
Strike | 24.00 |
Expiry date | 2024-10-18 |
Day's range | 8.00 - 8.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 45th Annual Global Healthcare Conference, June 11-12, 2024. Jeff Simmons, President and CEO, will participate in a fireside chat on Tuesday, June 11 at 2:40 p.m. ET.
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has completed its comprehensive, multi-year review of Bovaer® (3-NOP), a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle.